| Authors: |
Srinagesh HK; Division of Hematology/Oncology, Stanford University School of Medicine, Palo Alto, CA., Gupta V; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA., Zhang A; Quantitative Sciences Unit, Stanford University School of Medicine, Palo Alto, CA., Grunwald M; Division of Leukemia, Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC., Connor M; Division of Hematology and Oncology, Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, PA., Kota VK; Division of Hematology and Medical Oncology, Georgia Cancer Center at Augusta University, Augusta, GA., Boccucci J; Georgia Cancer Center, Medical College of Georgia, Augusta University, Augusta, GA., Ulrickson M; Section of Hematology, Banner MD Anderson Cancer Center, Gilbert, AZ., Pradeep R; Section of Hematology, Banner MD Anderson Cancer Center, Gilbert, AZ., Hill L; Section of Hematology and Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX., Tsai SB; Division of Hematology/Oncology, Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL., O'Connor T; Division of Hematology/Oncology, Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL., Sandhu K; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA., Advani AS; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH., Reshef R; Division of Hematology/Oncology, Blood and Marrow Transplantation and Cell Therapy Program, Columbia University Irving Medical Center, New York, NY., Gordillo CA; Division of Hematology/Oncology, Blood and Marrow Transplantation and Cell Therapy Program, Columbia University Irving Medical Center, New York, NY., Luskin MR; Division of Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Chen EC; Adult Leukemia Program, Dana-Farber Cancer Institute, Boston, MA., Lin C; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC., Cassaday RD; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA., Kopmar NE; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA., Majhail NS; Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center, HCA Healthcare, Nashville, TN., Battiwalla M; Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center, HCA Healthcare, Nashville, TN., Strickland SA; Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center, HCA Healthcare, Nashville, TN., Lee CJ; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Bobillo SO; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Hilal T; Department of Hematology and Oncology, Mayo Clinic, Phoenix, AZ., Park JH; Cell Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Valtis YK; Cell Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Faramand R; Moffitt Cancer Center and Research Institute, Tampa, FL., Solh MM; Northside Hospital Cancer Institute, Atlanta, GA., Guzowski C; Northside Hospital Cancer Institute, Atlanta, GA., Vasu S; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Leonard JT; Knight Cancer Institute, Department of Medical Oncology, Oregon Health and Science University, Portland, OR., Tan V; Knight Cancer Institute, Department of Medical Oncology, Oregon Health and Science University, Portland, OR., Wang ES; Division of Hematology and Oncology, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY., McCauley R; Division of Hematology and Oncology, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Sasine J; Division of Hematology and Cellular Therapy, Department of Medicine, Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA., Tang K; Division of Hematology and Cellular Therapy, Department of Medicine, Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA., Miller K; Quantitative Sciences Unit, Stanford University School of Medicine, Palo Alto, CA., Sutherland KC; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA., Daunov M; Division of Hematology and Oncology, UH Seidman Cancer Center, University Hospitals, Cleveland, OH., Mohty R; Division of Hematology and Oncology, O'Neal Comprehensive Cancer Center, The University of Alabama, Birmingham, AL., Jamy O; Division of Hematology and Oncology, O'Neal Comprehensive Cancer Center, The University of Alabama, Birmingham, AL., Kumaran MV; Stem Cell Transplantation and Cellular Therapy Program, University of Arkansas Medical Center, Little Rock, AR., Hoeg RT; Division of Malignant Hematology/Cellular Therapy and Transplantation, Department of Internal Medicine, University of California Davis, Sacramento, CA., Dykes KC; Division of Hematology and Cellular Therapy, University of California, San Diego, La Jolla, CA., Logan AC; Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, University of California San Francisco, San Francisco, CA., Othman T; Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, University of California San Francisco, San Francisco, CA., Stock W; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL., Schwartz M; Division of Hematology, Department of Medicine, University of Colorado, Aurora, CO., Byrd K; Division of Hematologic Malignancies and Cellular Therapeutics, Department of Medicine, University of Kansas School of Medicine, Kansas City, KS., Yalniz F; Division of Hematology and Blood Marrow Transplantation, Department of Medicine, University of Kentucky College of Medicine, Lexington, KY., Bachanova V; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN., Tracy S; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN., Yaghmour G; Department of Hematology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA., Irizarry Gatell VM; Division of Hematology/Oncology, University of Texas Southwestern, Dallas, TX., Jackson CW; Division of Hematology/Oncology, University of Texas Southwestern, Dallas, TX., Oluwole OO; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN., Dholaria B; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN., O'Dwyer KM; Division of Hematology and Oncology, Department of Medicine, Wilmot Cancer Institute of University of Rochester, Rochester, NY., Moore J; Division of Hematology and Oncology, Department of Medicine, Wilmot Cancer Institute of University of Rochester, Rochester, NY., Roloff GW; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL., Frey NV; Division of Hematology and Oncology, Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, PA., Aldoss I; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA., Shah BD; Moffitt Cancer Center and Research Institute, Tampa, FL., Oliai CH; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA., Muffly LS; Division of Hematology and Oncology, UH Seidman Cancer Center, University Hospitals, Cleveland, OH. |
